img

The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022
ad-image

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:

Opinion

View All

Iranian hackers shut down UK power facility in cyberattack: report

The facility was reportedly disabled for four days as staff worked to restore it....

Sword-wielding maniac kills 17-year-old girl, injures three others at Swedish high school

"First it was just a regular day really. But then ... I saw a guy all covered in blood, at least down...

LIBBY EMMONS and JACK POSOBIEC: Toxic femininity is to blame for privileged child-killer Lindsay Clancy

"If the future is female, here we are in the middle of it, and it doesn't look so great."...

Ambassador to Belgium to 'review' US relationship with Ghent University over 'scapegoating' of Nathan Cofnas for Jason Arday's death

"Dishonest, corrupt institutions that engage in, or reward, scapegoating mob behavior are not desirab...